Exhaustion - Chronic Fatigue

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-06-01
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:37:43

Label at a glance#

ProductExhaustion - Chronic Fatigue

Active ingredientAconitum Napellus, Epinephrine, American Ginseng, Arnica Montana, Arsenic Trioxide, Baptisia Tinctoria, Bryonia Alba Root, Lytta Vesicatoria, Chelidonium Majus, Cinchona Officinalis Bark, Iodine, Potassium Carbonate, Potassium Iodide, Lachesis Muta Venom, Lycopodium Clavatum Spore, Lycopus Virginicus, Sodium Chloride, Strychnos Nux-vomica Seed, Phosphorus, Pulsatilla Vulgaris, Toxicodendron Pubescens Leaf, Saw Palmetto, Thyroid, Unspecified, Echinacea, Unspecified, Ginkgo, Phytolacca Americana Root

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Exhaustion - Chronic Fatigue Formulated for symptoms associated with severe fatigue, Epstein-Barr, Chronic Fatigue Syndrome, adrenal exhaustion and other related conditions.

DOSAGE & ADMINISTRATION SECTION

Directions: Ages 12 and up, take 6 pellets orally (ages 6 to 11, give 3 pellets) as needed or as directed by a healthcare professional.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Aconitum nap. 20x, Adrenalinum 20x, Aralia quinquefolia 20x, Arnica 20x, Arsenicum alb. 20x, Baptisia 20x, Bryonia 20x, Cantharis 20x, Chelidonium majus 20x, Cinchona 20x, Iodium 20x, Kali carb. 20x, Kali iod. 20x, Lachesis 20x, Lycopodium 20x, Lycopus virginicus 20x, Nat. mur. 20x, Nux vom. 20x, Phosphorus 20x, Pulsatilla 20x, Rhus toxicodendron 20x, Sabal 20x, Thyroidinum 20x, Echinacea 8x, Gingko 8x, Phytolacca 8x, Echinacea 3x, Gingko 3x, Phytolacca 3x.

PURPOSE SECTION

ABUSE SECTION

Formulated for symptoms associated with severe fatigue, Epstein-Barr, Chronic Fatigue Syndrome, adrenal exhaustion and other related conditions.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Aconitum Napellus	ACTIVE INGREDIENT	U0NQ8555JD	1
American Ginseng	ACTIVE INGREDIENT	8W75VCV53Q	1
Arnica Montana	ACTIVE INGREDIENT	O80TY208ZW	1
Arsenic Trioxide	ACTIVE INGREDIENT	S7V92P67HO	1
Baptisia Tinctoria	ACTIVE INGREDIENT	5K1UO2888Y	1
Bryonia Alba Root	ACTIVE INGREDIENT	T7J046YI2B	1
Chelidonium Majus	ACTIVE INGREDIENT	7E889U5RNN	1
Cinchona Officinalis Bark	ACTIVE INGREDIENT	S003A158SB	1
Echinacea, Unspecified	ACTIVE INGREDIENT	4N9P6CC1DX	1
Epinephrine	ACTIVE INGREDIENT	YKH834O4BH	1
Ginkgo	ACTIVE INGREDIENT	19FUJ2C58T	1
Iodine	ACTIVE INGREDIENT	9679TC07X4	1
Lachesis Muta Venom	ACTIVE INGREDIENT	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE INGREDIENT	C88X29Y479	1
Lycopus Virginicus	ACTIVE INGREDIENT	TWH5125Q6F	1
Lytta Vesicatoria	ACTIVE INGREDIENT	3Q034RO3BT	1
Phosphorus	ACTIVE INGREDIENT	27YLU75U4W	1
Phytolacca Americana Root	ACTIVE INGREDIENT	11E6VI8VEG	1
Potassium Carbonate	ACTIVE INGREDIENT	BQN1B9B9HA	1
Potassium Iodide	ACTIVE INGREDIENT	1C4QK22F9J	1
Pulsatilla Vulgaris	ACTIVE INGREDIENT	I76KB35JEV	1
Saw Palmetto	ACTIVE INGREDIENT	J7WWH9M8QS	1
Sodium Chloride	ACTIVE INGREDIENT	451W47IQ8X	1
Strychnos Nux-vomica Seed	ACTIVE INGREDIENT	269XH13919	1
Thyroid, Unspecified	ACTIVE INGREDIENT	0B4FDL9I6P	1
Toxicodendron Pubescens Leaf	ACTIVE INGREDIENT	6IO182RP7A	1
Aconitum Napellus	ACTIVE MOIETY	U0NQ8555JD	1
American Ginseng	ACTIVE MOIETY	8W75VCV53Q	1
Arnica Montana	ACTIVE MOIETY	O80TY208ZW	1
Arsenic Cation (3+)	ACTIVE MOIETY	C96613F5AV	1
Baptisia Tinctoria	ACTIVE MOIETY	5K1UO2888Y	1
Bryonia Alba Root	ACTIVE MOIETY	T7J046YI2B	1
Carbonate Ion	ACTIVE MOIETY	7UJQ5OPE7D	1
Chelidonium Majus	ACTIVE MOIETY	7E889U5RNN	1
Chloride Ion	ACTIVE MOIETY	Q32ZN48698	1
Cinchona Officinalis Bark	ACTIVE MOIETY	S003A158SB	1
Echinacea, Unspecified	ACTIVE MOIETY	4N9P6CC1DX	1
Epinephrine	ACTIVE MOIETY	YKH834O4BH	1
Ginkgo	ACTIVE MOIETY	19FUJ2C58T	1
Iodide Ion	ACTIVE MOIETY	09G4I6V86Q	1
Iodine	ACTIVE MOIETY	9679TC07X4	1
Lachesis Muta Venom	ACTIVE MOIETY	VSW71SS07I	1
Lycopodium Clavatum Spore	ACTIVE MOIETY	C88X29Y479	1
Lycopus Virginicus	ACTIVE MOIETY	TWH5125Q6F	1
Lytta Vesicatoria	ACTIVE MOIETY	3Q034RO3BT	1
Phosphorus	ACTIVE MOIETY	27YLU75U4W	1
Phytolacca Americana Root	ACTIVE MOIETY	11E6VI8VEG	1
Pulsatilla Vulgaris	ACTIVE MOIETY	I76KB35JEV	1
Saw Palmetto	ACTIVE MOIETY	J7WWH9M8QS	1
Strychnos Nux-vomica Seed	ACTIVE MOIETY	269XH13919	1
Thyroid, Unspecified	ACTIVE MOIETY	0B4FDL9I6P	1
Toxicodendron Pubescens Leaf	ACTIVE MOIETY	6IO182RP7A	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

Exhaustion - Chronic Fatigue
Aconitum nap., Adrenalinum, Aralia quinquefolia, Arnica, Arsenicum alb., Baptisia, Bryonia, Cantharis, Chelidonium majus, Cinchona, Iodium, Kali carb., Kali iod., Lachesis, Lycopodium, Lycopus virginicus, Nat. mur., Nux vom., Phosphorus, Pulsatilla, Rhus toxicodendron, Sabal, Thyroidinum, Echinacea, Gingko, Phytolacca
Aconitum Napellus
Epinephrine
American Ginseng
Arnica Montana
Arsenic Trioxide
Arsenic Cation (3+)
Baptisia Tinctoria
Bryonia Alba Root
Lytta Vesicatoria
Chelidonium Majus
Cinchona Officinalis Bark
Iodine
Potassium Carbonate
Carbonate Ion
Potassium Iodide
Iodide Ion
Lachesis Muta Venom
Lycopodium Clavatum Spore
Lycopus Virginicus
Sodium Chloride
Chloride Ion
Strychnos Nux-vomica Seed
Phosphorus
Pulsatilla Vulgaris
Toxicodendron Pubescens Leaf
Saw Palmetto
Thyroid, Unspecified
Echinacea, Unspecified
Ginkgo
Phytolacca Americana Root
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-4553	55714-4553-1, 55714-4553-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Aconitum Napellus	U0NQ8555JD	ACTIB
Epinephrine	YKH834O4BH	ACTIB
American Ginseng	8W75VCV53Q	ACTIB
Arnica Montana	O80TY208ZW	ACTIB
Arsenic Trioxide	S7V92P67HO	ACTIB
Baptisia Tinctoria	5K1UO2888Y	ACTIB
Bryonia Alba Root	T7J046YI2B	ACTIB
Lytta Vesicatoria	3Q034RO3BT	ACTIB
Chelidonium Majus	7E889U5RNN	ACTIB
Cinchona Officinalis Bark	S003A158SB	ACTIB
Iodine	9679TC07X4	ACTIB
Potassium Carbonate	BQN1B9B9HA	ACTIB
Potassium Iodide	1C4QK22F9J	ACTIM
Lachesis Muta Venom	VSW71SS07I	ACTIB
Lycopodium Clavatum Spore	C88X29Y479	ACTIB
Lycopus Virginicus	TWH5125Q6F	ACTIB
Sodium Chloride	451W47IQ8X	ACTIB
Strychnos Nux-vomica Seed	269XH13919	ACTIB
Phosphorus	27YLU75U4W	ACTIB
Pulsatilla Vulgaris	I76KB35JEV	ACTIB
Toxicodendron Pubescens Leaf	6IO182RP7A	ACTIB
Saw Palmetto	J7WWH9M8QS	ACTIB
Thyroid, Unspecified	0B4FDL9I6P	ACTIB
Echinacea, Unspecified	4N9P6CC1DX	ACTIB
Ginkgo	19FUJ2C58T	ACTIB
Phytolacca Americana Root	11E6VI8VEG	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
98bf6ca0-9bc0-25b2-e053-2995a90afd10			108ab0a7-9eee-236a-f36f-e9a248bd3a81	2019-12-02	Warnings	Exact identifier spl set id: 108ab0a7-9eee-236a-f36f-e9a248bd3a81

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.